BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 19085650)

  • 1. Genetics of bleeding disorders in women.
    Novelli EM; Ragni MV
    Semin Thromb Hemost; 2008 Sep; 34(6):509-19. PubMed ID: 19085650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
    Gupta PK; Charan VD; Saxena R
    Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic aspects of hemostasis. A review.
    Quick AJ
    Thromb Diath Haemorrh; 1968 Nov; 20(1):209-26. PubMed ID: 4884913
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical problem of hereditary hemorrhagic diseases developing prolonged bleeding time].
    Bello A; Dorantes S; Enriqueta Zamudio M; Alvarez Amaya C; Killnee MS
    Bol Med Hosp Infant Mex; 1975; 32(2):227-48. PubMed ID: 1079731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand disease and platelet disorders.
    Favaloro EJ; Bodó I; Israels SJ; Brown SA
    Haemophilia; 2014 May; 20 Suppl 4():59-64. PubMed ID: 24762277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of molecular genetics in diagnosing von Willebrand disease.
    James P; Lillicrap D
    Semin Thromb Hemost; 2008 Sep; 34(6):502-8. PubMed ID: 19085649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rendu-Osler-Weber disease (review of the literature)].
    Livandovskiĭ IuA
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):43-7. PubMed ID: 4919379
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic testing for von Willebrand disease: the Canadian experience.
    James P; Lillicrap D
    Semin Thromb Hemost; 2006 Jul; 32(5):546-52. PubMed ID: 16862529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
    Franchini M; Montagnana M; Lippi G
    Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Constitutional abnormalities of hemostasis: diagnostic strategy].
    Biermé R
    Rev Prat; 1989 Dec; 39(30):2665-8. PubMed ID: 2617060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited bleeding disorders in older women.
    Kadir RA; Sharief LA; Lee CA
    Maturitas; 2012 May; 72(1):35-41. PubMed ID: 22445218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of genetics to inherited bleeding disorders.
    James P; Di Paola J
    Haemophilia; 2010 Jul; 16 Suppl 5():35-9. PubMed ID: 20590854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders.
    Sidonio RF; Bryant PC; Di Paola J; Hale S; Heiman M; Horowitz GS; Humphrey C; Jaffray J; Joyner LC; Kasthuri R; Konkle BA; Kouides PA; Montgomery R; Neeves K; Randi AM; Scappe N; Tarango C; Tickle K; Trapane P; Wang M; Waters B; Flood VH
    Expert Rev Hematol; 2023 Mar; 16(sup1):39-54. PubMed ID: 36920856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
    Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M;
    Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible.
    Pereira J; Quiroga T; Mezzano D
    Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological review of hemostasis].
    Launay F
    Neurochirurgie; 1973; 19(3):259-64. PubMed ID: 4547605
    [No Abstract]   [Full Text] [Related]  

  • 20. Menorrhagia and bleeding disorders.
    El-Hemaidi I; Gharaibeh A; Shehata H
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):513-20. PubMed ID: 18007127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.